Home
StockRanks™
Platform
Insights
Research & Discuss
Editorial & Community
Learn & Improve
Webinars & Masterclasses
Stockopedia Academy
Reviews
Pricing
Get started
Log in
Sectors
Consumer Defensives
Food & Drug Retailing
EQL Pharma AB
EQL —
EQL Pharma AB
News Story
SEK22.70
0.00
0.00%
Last trade -
00:00
Consumer Defensives
Speculative
Small Cap
Neutral
Market Cap
SEK670.32m
Enterprise Value
SEK1.07bn
Revenue
SEK432.66m
Quality
Value
Momentum
Stock
Rank
™
StockReport™
Accounts
Balance sheet
Income statement
Cashflow statement
Dividend summary
News
EQL Dividends
StockReport™
Balance sheet
Income statement
Cashflow
News
EQL Dividends
All News
Brief: EQL Pharma Q1 Adjusted Revenue SEK 56.2 Million
EQL Pharma AB
16/08/2023 17:00
Aug 16 (Reuters) - EQL Pharma Q1 revenue SEK 56.2 million
Recent news on EQL Pharma AB
See all news
Brief: EQL Says Memprex Licensed For Sale In Hungary
12/08/2026 12:47
Brief: Eql Pharma Q1 EBIT Loss SEK 13.7 Mln
07/08/2026 06:02
Brief: EQL Pharma: Mellozzan Approved For Sale In Kazakhstan
15/07/2026 08:59
Brief: EQL Secures Memprex Licence With Partner For Spain
13/07/2026 14:16
Brief: EQL Pharma Q4 EBIT SEK 5.1 Mln
08/05/2026 06:14